Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SK&F 102698

Known as: SK&F-102698, SKF 102698 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The effect of 6-chloro-2,3,4,5-tetrahydro-3-methyl-1-H-3-benzazepine (SKF 86466), a selective nonimidazoline alpha-2 adrenoceptor… Expand
1991
1991
The acute and chronic effects of a potent selective dopamine beta-hydroxylase inhibitor, SK&F 102698, were assessed in… Expand
1990
1990
The acute and chronic effects of a potent and selective dopamine β-hydroxylase inhibitor, SK&F 102698 [l-(3,5-difluorobenzyl… Expand
1990
1990
The acute and chronic effects of a potent and selective dopamine beta-hydroxylase inhibitor, SK&F 102698 [1-(3,5-difluorobenzyl… Expand
1990
1990
Dopamine (DA) is synthesized in the renal proximal convoluted tubule (PCT) and may act as a paracrine substance at tubular DA-1… Expand
1988
1988
The novel dopamine beta-hydroxylase (D beta H) inhibitor SK&F 102698 was characterized in vitro with soluble enzyme from bovine… Expand
1988
1988
The dopamine beta-hydroxylase inhibitor SK&F 102698 was characterized by studying its cardiovascular effects in hypertensive rats… Expand
1987
1987
The cardiovascular effects of a new class of potent inhibitors of dopamine beta-hydroxylase (DBH) were evaluated in spontaneously… Expand
Review
1987
Review
1987
The ability to stimulate dopamine receptors in the heart and blood vessels with selective receptor agonists, such as fenoldopam… Expand